The approval allows Eugia Pharma to manufacture and market a bioequivalent and therapeutically equivalent product to Mozobil Injection by Genzyme Corporation
Subscribe To Our Free Newsletter |
The approval allows Eugia Pharma to manufacture and market a bioequivalent and therapeutically equivalent product to Mozobil Injection by Genzyme Corporation
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!